Nautilus Biotechnology (NAUT) Net Income (QoQ) (2020 - 2021)

Nautilus Biotechnology (NAUT) Net Income (QoQ) (2020 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 472.40 Bn 467.61 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.23 Bn 114.98 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 62.46 Bn 62.46 Bn -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Nautilus Biotechnology 212.75 Mn 116.88 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 -51.16%
Dec 31, 2020 -134.66%